Treatment Patterns, Safety, and Patient Reported Outcomes among Adult Women with Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer with or without, or with Unknown, BRCA1/2 Mutation(s): Results of a Real-World Study from the United States, United Kingdom, and four EU Countries

INTRODUCTION: This real-world study assessed the breast cancer susceptibility gene 1 or 2 mutation (BRCA1/2mut) status on treatment patterns, safety, and patient-reported outcomes (PROs) in women with human epidermal growth factor receptor 2-negative (HER2−) advanced breast cancer (ABC) in the USA,...

Descripción completa

Detalles Bibliográficos
Autores principales: Lux, Michael Patrick, Lewis, Katie, Rider, Alex, Niyazov, Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9851071/
https://www.ncbi.nlm.nih.gov/pubmed/36684399
http://dx.doi.org/10.1159/000523970

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9851071/
https://www.ncbi.nlm.nih.gov/pubmed/36684399
http://dx.doi.org/10.1159/000523970

Ejemplares similares